Animal models of tumor immunity, immunotherapy and cancer vaccines

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• Traditional tumor transplantation models inadequately represent human malignancies.
• Advancements in tumor immunology necessitate more accurate preclinical models.
• Spontaneously arising tumors in transgenic mice offer improved human cancer relevance.

Purpose of the Study:

• To review the development and application of transgenic mouse models for cancer immunotherapy research.
• To highlight the technologies utilized in creating sophisticated animal models for tumor immunology.
• To discuss the importance of these models in understanding the tumor-host relationship.

Main Methods:

• Utilizing tissue-specific promoters to drive oncogene expression (e.g., SV40 large T antigen).
• Employing gene targeting for the deletion of tumor suppressor genes.
• Implementing Cre-lox technology for conditional gene manipulation (deletion or activation).
• Developing knockin mice expressing human tumor antigens and gene-targeted models with specific molecular deletions.

Main Results:

• Transgenic mouse models now exist for most cancer types, enabling spontaneous tumor development.
• These models facilitate the study of tumor immunology and the tumor-host interaction.
• Knockin and gene-targeted mice have significantly advanced understanding of tumor immunology.

Conclusions:

• Sophisticated transgenic mouse models are essential for evaluating cancer immunotherapies.
• Current models provide superior representation of human cancers compared to older systems.
• Continued refinement of animal models is needed for even greater realism in preclinical research.